102 related articles for article (PubMed ID: 16213303)
1. Signs and symptoms of cytomegalovirus disease in kidney transplant recipients.
Pour-Reza-Gholi F; Labibi A; Farrokhi F; Nafar M; Firouzan A; Einollahi B
Transplant Proc; 2005 Sep; 37(7):3056-8. PubMed ID: 16213303
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestation, laboratory findings, and the response of treatment in kidney transplant recipients with CMV infection.
Razeghi E; Hadadi A; Mansor-Kiaei M; Molavi M; Khashayar P; Pourmand G
Transplant Proc; 2007 May; 39(4):993-6. PubMed ID: 17524872
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
Boucher A; Lord H; Collette S; Morin M; Dandavino R
Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
[TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients.
John GT; Manivannan J; Chandy S; Peter S; Fleming DH; Chandy SJ; Balakrishnan N; Krishnamurthy K; Kirubakaran MG; Jacob CK
Transplant Proc; 2005 Dec; 37(10):4303-5. PubMed ID: 16387103
[TBL] [Abstract][Full Text] [Related]
6. A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients.
Nafar M; Pezeshki ML; Farrokhi F; Einollahi B; Pour-Reza-Gholi F; Firouzan A; Farhangi S
Transplant Proc; 2005 Sep; 37(7):3053-5. PubMed ID: 16213302
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus disease after kidney transplantation: clues to accurate diagnosis.
Nemati E; Eizadi M; Lankarani MM; Kardavani B; Khoddami-Vishteh HR; Kalantar E; Lesan-Pezeshki M; Khedmat H; Saadat AR
Transplant Proc; 2007 May; 39(4):987-9. PubMed ID: 17524870
[TBL] [Abstract][Full Text] [Related]
8. Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.
Boobes Y; Al Hakim M; Dastoor H; Bernieh B; Abdulkhalik S
Transplant Proc; 2004; 36(6):1841-3. PubMed ID: 15350493
[TBL] [Abstract][Full Text] [Related]
9. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
[TBL] [Abstract][Full Text] [Related]
10. Oral ulcers during the course of cytomegalovirus infection in renal transplant recipients.
López-Pintor RM; Hernández G; de Arriba L; Morales JM; Jiménez C; de Andrés A
Transplant Proc; 2009; 41(6):2419-21. PubMed ID: 19715938
[TBL] [Abstract][Full Text] [Related]
11. Polyoma virus-associated nephropathy and concurrent cytomegalovirus infection in the kidney transplant recipients.
Park SB; Kwak JH; Lee KT; Hwang EA; Han SY; Kim HT; Cho WH; Choi MS; Kim HC
Transplant Proc; 2006 Sep; 38(7):2059-61. PubMed ID: 16979999
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infections in cardiac transplant patients: an experience at a clinical hospital, university of Chile.
Sepulveda L; Llancaqueo M; Zamorano J; Bermudez C; Cortes C
Transplant Proc; 2007 Apr; 39(3):622-4. PubMed ID: 17445560
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
[TBL] [Abstract][Full Text] [Related]
14. Late and atypical cytomegalovirus disease in solid-organ transplant recipients.
Slifkin M; Tempesti P; Poutsiaka DD; Snydman DR
Clin Infect Dis; 2001 Oct; 33(7):E62-8. PubMed ID: 11528587
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
[TBL] [Abstract][Full Text] [Related]
16. Gancyclovir prophylaxis in high risk patients.
Campino A
Transplant Proc; 2005 Dec; 37(10):4311-2. PubMed ID: 16387106
[TBL] [Abstract][Full Text] [Related]
17. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection in renal transplant recipients.
Carstens J; Andersen HK; Spencer E; Madsen M
Transpl Infect Dis; 2006 Dec; 8(4):203-12. PubMed ID: 17116133
[TBL] [Abstract][Full Text] [Related]
19. 24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course.
Doyle AM; Warburton KM; Goral S; Blumberg E; Grossman RA; Bloom RD
Transplantation; 2006 Apr; 81(8):1106-11. PubMed ID: 16641594
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus disease in kidney transplant recipients: incidence, clinical profile, and risk factors.
Cordero E; Casasola C; Ecarma R; Danguilan R
Transplant Proc; 2012 Apr; 44(3):694-700. PubMed ID: 22483471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
